Baoli Qin

机构：Liaoning Cancer Hospital & Institute · ORCID：0000-0003-2591-1217

发表论文 11 篇 · 总被引 296 次 · h-index 6

代表论文

• Anlotinib Monotherapy for Refractory Metastatic Colorectal Cancer: A Double-Blinded, Placebo-Controlled, Randomized Phase III Trial (ALTER0703) (2021 · The Oncologist · 被引 64)
• Nimotuzumab Plus Gemcitabine for K-Ras Wild-Type Locally Advanced or Metastatic Pancreatic Cancer (2023 · Journal of Clinical Oncology · 被引 60)
• <p>Identification of seven-gene signature for prediction of lung squamous cell carcinoma</p> (2019 · OncoTargets and Therapy · 被引 54)
• Prognostic and clinicopathological significance of long noncoding RNA CTD-2510F5.4 in gastric cancer (2018 · Gastric Cancer · 被引 37)
• Andrographolide enhanced 5-fluorouracil-induced antitumor effect in colorectal cancer via inhibition of c-MET pathway (2017 · Drug Design Development and Therapy · 被引 35)
• Electrochemical Detection of VEGF165 Lung Cancer Marker Based on Au-Pd Alloy Assisted Aptasenor (2017 · International Journal of Electrochemical Science · 被引 25)